Literature DB >> 30027909

Neurofibrillary tangles mediated human neuronal tauopathies: insights from fly models.

Surajit Sarkar1.   

Abstract

Tauopathies represent a group of neurodegenerative disorder which are characterized by the presence of tau positive specialized argyrophilic and insoluble intraneuronal and glial fibrillar lesions known as neurofibrillary tangles (NFTs). Tau is a neuron specific microtubule binding protein which is required for the integrity and functioning of neuronal cells, and hyperphosphorylation of tau and its subsequent aggregation and paired helical filaments (PHFs) and NFTs has emerged as one of the major pathogenic mechanisms of tauopathies in human and mammalian model systems. Modeling of human tauopathies in Drosophila results in manifestation of associated phenotypes, and a recent study has demonstrated that similar to human and mammalian models, accumulation of insoluble tau aggregates in the form of typical neurotoxic NFTs triggers the pathogenesis of tauopathies in fly models. In view of the availability of remarkable genetic tools, Drosophila tau models could be extremely useful for in-depth analysis of the role of NFTs in neurodegeneration and tau aetiology, and also for the screening of novel gene(s) and molecule(s) which suppress the toxicity of tau aggregates.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30027909

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  82 in total

Review 1.  Pathways of tau fibrillization.

Authors:  Jeff Kuret; Carmen N Chirita; Erin E Congdon; Theresa Kannanayakal; Guibin Li; Mihaela Necula; Haishan Yin; Qi Zhong
Journal:  Biochim Biophys Acta       Date:  2005-01-03

Review 2.  Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).

Authors:  Dennis W Dickson; Naomi Kouri; Melissa E Murray; Keith A Josephs
Journal:  J Mol Neurosci       Date:  2011-07-01       Impact factor: 3.444

3.  The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.

Authors:  P J Lu; G Wulf; X Z Zhou; P Davies; K P Lu
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

4.  Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.

Authors:  Jean C Augustinack; Anja Schneider; Eva-Maria Mandelkow; Bradley T Hyman
Journal:  Acta Neuropathol       Date:  2002-01       Impact factor: 17.088

Review 5.  Frontotemporal dementia: implications for understanding Alzheimer disease.

Authors:  Michel Goedert; Bernardino Ghetti; Maria Grazia Spillantini
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

6.  Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model.

Authors:  Y P Wang; J Biernat; M Pickhardt; E Mandelkow; E-M Mandelkow
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

7.  Postmortem 3-D brain hemisphere cortical tau and amyloid-β pathology mapping and quantification as a validation method of neuropathology imaging.

Authors:  Lojze M Smid; Vladimir Kepe; Harry V Vinters; Mara Bresjanac; Tatsushi Toyokuni; Nagichettiar Satyamurthy; Koon-Pong Wong; Sung-Cheng Huang; Daniel H S Silverman; Karen Miller; Gary W Small; Jorge R Barrio
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

8.  Tyrosine phosphorylation of tau by the SRC family kinases lck and fyn.

Authors:  Timothy Me Scales; Pascal Derkinderen; Kit-Yi Leung; Helen L Byers; Malcolm A Ward; Caroline Price; Ian N Bird; Timothy Perera; Stuart Kellie; Ritchie Williamson; Brian H Anderton; C Hugh Reynolds
Journal:  Mol Neurodegener       Date:  2011-01-26       Impact factor: 14.195

9.  Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.

Authors:  Justin M Nussbaum; Stephan Schilling; Holger Cynis; Antonia Silva; Eric Swanson; Tanaporn Wangsanut; Kaycie Tayler; Brian Wiltgen; Asa Hatami; Raik Rönicke; Klaus Reymann; Birgit Hutter-Paier; Anca Alexandru; Wolfgang Jagla; Sigrid Graubner; Charles G Glabe; Hans-Ulrich Demuth; George S Bloom
Journal:  Nature       Date:  2012-05-02       Impact factor: 49.962

Review 10.  Tau Biology and Tau-Directed Therapies for Alzheimer's Disease.

Authors:  Lidia Bakota; Roland Brandt
Journal:  Drugs       Date:  2016-03       Impact factor: 9.546

View more
  1 in total

1.  UBE4B, a microRNA-9 target gene, promotes autophagy-mediated Tau degradation.

Authors:  Manivannan Subramanian; Seung Jae Hyeon; Tanuza Das; Yoon Seok Suh; Yun Kyung Kim; Jeong-Soo Lee; Eun Joo Song; Hoon Ryu; Kweon Yu
Journal:  Nat Commun       Date:  2021-06-02       Impact factor: 14.919

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.